Ignite Creation Date:
2025-12-24 @ 5:08 PM
Ignite Modification Date:
2026-01-24 @ 2:28 AM
Study NCT ID:
NCT00407550
Status:
COMPLETED
Last Update Posted:
2019-05-02
First Post:
2006-12-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Pemetrexed Disodium and Gemcitabine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
Sponsor:
Mayo Clinic
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CDR0000516012
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | NIH | View |